Cargando…
PCSK9 and the Gut-Liver-Brain Axis: A Novel Therapeutic Target for Immune Regulation in Alcohol Use Disorder
Alcohol use disorder (AUD) is a chronic relapsing disorder characterized by an impaired ability to control or stop alcohol intake and is associated with organ damage including alcohol-associated liver disease (ALD) and progressive neurodegeneration. The etiology of AUD is complex, but organ injury d...
Autores principales: | Lee, Ji Soo, O’Connell, Emma M., Pacher, Pal, Lohoff, Falk W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074019/ https://www.ncbi.nlm.nih.gov/pubmed/33919550 http://dx.doi.org/10.3390/jcm10081758 |
Ejemplares similares
-
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in the Brain and Relevance for Neuropsychiatric Disorders
por: O’Connell, Emma M., et al.
Publicado: (2020) -
PCSK9 inhibition as a novel therapeutic target for alcoholic liver disease
por: Lee, Ji Soo, et al.
Publicado: (2019) -
Methylomic profiling and replication implicates deregulation of PCSK9 in alcohol use disorder
por: Lohoff, Falk W., et al.
Publicado: (2017) -
Assessing the Impact of PCSK9 and HMGCR Inhibition on Liver Function: Drug-Target Mendelian Randomization Analyses in Four Ancestries
por: Rosoff, Daniel B., et al.
Publicado: (2023) -
Comparing the Relationships of Genetically Proxied PCSK9 Inhibition With Mood Disorders, Cognition, and Dementia Between Men and Women: A Drug‐Target Mendelian Randomization Study
por: Bell, Andrew S., et al.
Publicado: (2022)